During the annual Why I Changed My Mind event, three Harvard Law School faculty members shared how their experiences in government, advocacy, and academia reshaped their views.
The Slade Lab applies insights gleaned from AI-generated simulations to build real-world biomedical devices with the potential to improve the everyday lives of people with motor challenges.
The Harvard-led Undiagnosed Diseases Network has discovered nearly 100 rare conditions, including a disorder that led a father to lose his vision but was diagnosed in time to help his son.
Join fellow alumni from across Harvard to hear from President Alan M. Garber AB ’77, PhD ’82 and Provost John Manning AB ’82, JD ’85. Vanessa Liu AB ’96, JD ’01 will moderate this live conversation for the Harvard alumni community.
Legendary basketball player, writer, and activist Kareem Abdul-Jabbar will address the Harvard College Class of 2025 during the annual Class Day celebration on May 28.
Economist John Y. Campbell, an expert in long-term investing and endowment management, discusses the delicate balance between addressing Harvard’s immediate financial needs and safeguarding its endowment for the future.
Research by Travis Donahoe PhD '23 finds that enforcement actions targeting suppliers that profit from the opioid crisis, rather than the vulnerable individuals swept up in it, are a critical way to stem the tide of addiction and death.
Harvard students are breaking bread and bridging divides through “Our Harvard,” a student-led effort to foster dialogue across differences and offer varied perspectives on a range of issues.
Federally funded research by Harvard scholars has led to life-changing solutions to real-world problems facing millions of Americans, from preventing opioid deaths to treating diseases to building a better air conditioner.
Alberto Ascherio MPH ’89, DPH ’92 was honored for work establishing a link between Epstein-Barr virus and multiple sclerosis, Joel Habener for contributions to the development of GLP-1 drugs, and David Liu for the development of the gene editing platforms.
A Harvard patient-scientist and her husband are among the researchers behind a gene-editing technique that could lead to a treatment for a handful of rare, fatal disorders caused by misfolded proteins in the brain.
Scientist and physician Richard P. Lifton, a prominent leader in biomedical research and higher education, will become a fellow of Harvard College on July 1.
The inaugural session of Ethics IRL, a new series organized by the Edmond and Lily Safra Center for Ethics, focused on the ethical dilemmas of social media’s impact on higher education.
Inspired by his experience with malaria as a child in Ghana, Wyss Institute scientist Kwasi Adu-Berchie SM ’18, PhD ’22 is working to make health care more equitable globally.
Voting is now open for Harvard's Board of Overseers and HAA Elected Directors. Alumni can vote online or by paper ballot for up to six candidates for Overseer and up to six candidates for Elected Director. Voting closes on May 20.
A new University-wide pilot initiative will support faculty working in collaboration with leaders in government, nonprofits, and the private sector to develop solutions to pressing societal problems.
As a graduate student, Rob Devlin PhD ’17 helped develop an innovative mini-lens. Now he runs a startup that produces millions of the devices for use in an array of consumer electronics.
